An Overview Of Synthetic Hormone: A Potential Treatment Option For Menopausal Symptoms And To Stimulate Breast Milk Production
Synthetic hormones are produced by synthesis using urine from pregnant mares. One of the most well-known applications of synthetic hormones is that of bioidentical hormones. These are actually created from a combination of natural hormones extracted from cows, and they are commonly used to treat menopausal symptoms and to stimulate breast milk production in nursing mothers. Bioidentical hormones do not contain anything artificial, so they are 100 percent safe for use in both men and women. This is one reason why bioidentical hormones are the most popular synthetic hormones on the market today.
Another popular synthetic hormones is
that of progestin. This is actually the trade name for the drug metformin,
which is taken in pill form. Progesterone is actually one of the body's natural
estrogen precursors, so it is no surprise that when a woman is experiencing a
lack of estrogen the most common treatment is a low dose of synthetic hormones
to mimic this hormone. While this approach has been extremely successful in
treating a number of female disorders, including premenstrual syndrome and
menopausal issues, the side effects of this treatment can be very unpleasant,
and metformin has even been found to increase the risk of certain types of
cancer.
The major advantage of using
bioidentical hormones is that there is no risk of side effects, as there is
with synthetic hormones. Moreover, synthetic hormones carry the possibility of
causing breast cancer, which is not the case with endogenous hormones. There is
also the potential for allergic reactions to synthetic hormones, whereas no
such problems are associated with endogenous hormones. For many women who wish
to maintain their fertility and have a healthy reproductive system, synthetic
hormones can be a useful means of achieving these goals. In Germany, a new
treatment option is available for women with advanced breast cancer, who are resistant
to hormone therapy. Furthermore, in January 2021, rBIO, a U.S.-based synthetic
biology company, has achieved the synthetic production of insulin using rDNA
technology to synthesize peptide hormones and proteins.
Comments
Post a Comment